Gabapentin NDC 71335-1287

Product information

Brand name (proprietary)

Gabapentin

Generic name (nonproprietary)

gabapentin

Active ingredients

Gabapentin — 600 mg/1

Dosage form

Tablet, Coated

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207057

Marketing start

May 1, 2019

Listing expires

Dec 31, 2027

Other FDA classes

Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)

Identifiers

Product ID 71335-1287_1d171bd2-0093-4327-9111-e883bd241e8cSPL ID 1d171bd2-0093-4327-9111-e883bd241e8cSPL set ID d8604417-9d43-4d27-a7ce-d4120ff201f4RxCUI 310433UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335128700 followed by a unit qualifier and the quantity Copy

Package 71335-1287-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207057

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.